Bohai Pharmaceuticals Group, Inc.
company.status.inactiveCIK 1443242fmd_02YWXJV6CEZZW1B3MZDWQJ41B1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2009 to Sep 30, 2014, 18 periods
Latest annual · FY2014
Millions- Total revenues
- 175
- Gross profit
- 133
- Operating income
- 32
- Net income
- 22
- Free cash flow
- 25
Latest quarter · Q1 FY2015
Millions- Total revenues
- 55
- Gross profit
- 39
- Operating income
- 13
- Net income
- 9
- Free cash flow
- 9
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2011 to FY2014
- n/m
Bohai Pharmaceuticals Group, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Revenue | $175.1 million | $151.8 million | +15.3% | 10-K/A 2014-10-21 · proof |
| Gross profit | $132.7 million | $114.6 million | +15.8% | 10-K/A 2014-10-21 · proof |
| Operating income | $32.4 million | $26.9 million | +20.6% | 10-K/A 2014-10-21 · proof |
| Net income | $21.9 million | $19.1 million | +14.5% | 10-K/A 2014-10-21 · proof |
| Cash from operating activities | $25 million | $20.6 million | +21.6% | 10-K/A 2014-10-21 · proof |
| Free cash flow | $25.5 million | $24.5 million | +3.8% | 10-K/A 2014-10-21 · proof |
| Total assets | $184.8 million | $165.6 million | +11.6% | 10-K/A 2014-10-21 · proof |
| Total liabilities | $55.2 million | $57.2 million | -3.6% | 10-K/A 2014-10-21 · proof |
| Cash and cash equivalents | $23.3 million | $6.9 million | +235.5% | 10-K/A 2014-10-21 · proof |
- What was Bohai Pharmaceuticals Group, Inc.'s revenue in fiscal 2014?
- Bohai Pharmaceuticals Group, Inc. reported revenue of $175.1 million for fiscal 2014 (the year ended Jun 30, 2014), against $151.8 million the year before (+15.3%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What was Bohai Pharmaceuticals Group, Inc.'s gross profit in fiscal 2014?
- Bohai Pharmaceuticals Group, Inc. reported gross profit of $132.7 million for fiscal 2014 (the year ended Jun 30, 2014), against $114.6 million the year before (+15.8%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What was Bohai Pharmaceuticals Group, Inc.'s operating income in fiscal 2014?
- Bohai Pharmaceuticals Group, Inc. reported operating income of $32.4 million for fiscal 2014 (the year ended Jun 30, 2014), against $26.9 million the year before (+20.6%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What was Bohai Pharmaceuticals Group, Inc.'s net income in fiscal 2014?
- Bohai Pharmaceuticals Group, Inc. reported net income of $21.9 million for fiscal 2014 (the year ended Jun 30, 2014), against $19.1 million the year before (+14.5%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What was Bohai Pharmaceuticals Group, Inc.'s cash from operating activities in fiscal 2014?
- Bohai Pharmaceuticals Group, Inc. reported cash from operating activities of $25 million for fiscal 2014 (the year ended Jun 30, 2014), against $20.6 million the year before (+21.6%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What was Bohai Pharmaceuticals Group, Inc.'s free cash flow in fiscal 2014?
- Bohai Pharmaceuticals Group, Inc. reported free cash flow of $25.5 million for fiscal 2014 (the year ended Jun 30, 2014), against $24.5 million the year before (+3.8%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What are Bohai Pharmaceuticals Group, Inc.'s total assets?
- As of Jun 30, 2014, Bohai Pharmaceuticals Group, Inc. reported total assets of $184.8 million, against $165.6 million a year earlier (+11.6%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What are Bohai Pharmaceuticals Group, Inc.'s total liabilities?
- As of Jun 30, 2014, Bohai Pharmaceuticals Group, Inc. reported total liabilities of $55.2 million, against $57.2 million a year earlier (-3.6%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
- What are Bohai Pharmaceuticals Group, Inc.'s cash and cash equivalents?
- As of Jun 30, 2014, Bohai Pharmaceuticals Group, Inc. reported cash and cash equivalents of $23.3 million, against $6.9 million a year earlier (+235.5%). Source: the 10-K/A filed with the SEC on Oct 21, 2014. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1443242&period_type=annual&limit=5"Information only, not investment advice.